Legend Biotech (LEGN) Gross Margin (2022 - 2026)
Legend Biotech's Gross Margin came in at 64.90% for Q2 2026, up 2.10 percentage points from 62.80% a year earlier and up 22.39 percentage points from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Gross Margin (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Legend Biotech reported Gross Margin of 57.20%, down 6.87 percentage points year-over-year; for FY2025, it was 61.41%, down 4.10 percentage points from FY2024.
- Gross Margin carries a five-year change of -38.59 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 65.50% in FY2024 (+16.08 pp), 49.42% in FY2023 (+5.28 pp), 44.14% in FY2022 (-55.86 pp) and 100.00% in FY2021 (unchanged).
- The Q2 2026 figure represents the highest quarterly Gross Margin since Q3 2024.
- Year-over-year, Gross Margin increased in four of the last eight quarters, with an average year-over-year change of -1.31 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q3 2023 (a gain of 47.77 percentage points), and the weakest in Q1 2026 (a drop of 21.85 percentage points).
- Business Quant data shows LEGN's Gross Margin at 42.51% (Q1 2026), 61.00% (Q4 2025) and 58.41% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Legend Biotech | 3.43 Bn | -308.34 Mn | 251.50 Mn | 64.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.90% |
| Mar 31, 2026 | 42.51% |
| Dec 31, 2025 | 61.00% |
| Sep 30, 2025 | 58.41% |
| Jun 30, 2025 | 62.80% |
| Mar 31, 2025 | 64.36% |
| Dec 31, 2024 | 62.79% |
| Sep 30, 2024 | 67.22% |
| Jun 30, 2024 | 75.68% |
| Mar 31, 2024 | 47.76% |
| Dec 31, 2023 | 59.16% |
| Sep 30, 2023 | 54.72% |
| Jun 30, 2023 | 55.45% |
| Mar 31, 2023 | 1.99% |
| Dec 31, 2022 | 16.90% |
| Sep 30, 2022 | 6.95% |
API Access
Legend Biotech Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();